As AI continues to evolve, the semiconductor industry is one of many fields where investors are seeing immense opportunities and benefits from the technology. Senior Semiconductors and Automotive Technologies Analyst Vijay Rakesh examines the AI technology landscape and what this means for the industry.

When life circumstances create challenges for high school students, transfer schools and organizations like Comprehensive Youth Development (CYD) step in to offer alternatives, providing flexible classroom hours, manageable graduation time horizons, and additional support in the form of tutoring, mentoring, and social services. The Mizuho USA Foundation is proud to support CYD and its Preparation Meets Opportunity program, which provides workplace readiness training for students at a high-need public transfer school in Manhattan.

When will the IPO markets reopen? Few are better placed to answer this question than Lise Buyer, founder of IPO advisory firm, Class V Group.

AI was at the heart of conversations at the 2023 Fortune Brainstorm Tech Conference. Optimism around this massive tech innovation was plentiful, tempered by the need for regulation, governance and guardrails for this unchartered opportunity. Excitement and enthusiasm were also high around investments, as last year’s market uncertainty eases and the IPO market shows signs of returning.

With a general slowdown in M&A and Capital Markets activity, pharma and biotech are leading the charge with large announced deals, successful acquisition financings and evidence of green shoots seen in the equity capital markets. Hear from our experts on what is driving the sector activity and what we expect for the remainder of the year.

Founded in 2014, COOP Careers provides underemployed, first-generation and Pell Grant college graduates with opportunities to expand their professional skills and networks in order to launch a meaningful career and fuel upward mobility. Mizuho is thrilled to support COOP and its SMB Client project, aiming to provide participants with hands-on work experience in industries including Digital Marketing, Data Analytics, and Business Development.

An increasing number of companies are developing treatments for neurodegenerative disorders and their symptoms – many of which are showing promising data. The positive outlook could be an emerging opportunity for investors to target smaller drug makers. Graig Suvannavejh, Senior US Healthcare Equity Research Analyst examines how the new age of neuro drug development is creating a major pathway for investors.

Members of Mizuho's Biotech, Healthcare, and REITs Equity Research teams are back for another edition of Mizuho Collaborates, where they discuss the latest developments at the intersection of life sciences and real estate.

Pursuit is an innovative social impact organization focusing on closing the prosperity gap in America, transforming the lives of New Yorkers from low-income backgrounds through its no-cost engineering training programs. Mizuho is proud to partner with Pursuit to further accelerate and support the hundreds of young adults in their career and professional development.